Recent Blogs

Comprehensive Independent Assessment Entity Award Announcement

Friday, January 31, 2020

Behavioral Health I/DD Tailored Plan Request for Applications (RFA) Pre-Release Policy Paper

Thursday, January 30, 2020

Telephonic Evaluation and Management for Influenza

Tuesday, January 28, 2020

Crizanlizumab-tmca Injection, for Intravenous use (Adakveo®) HCPCS Code J3590: Billing Guidelines

Tuesday, January 28, 2020

Immune Globulin Intravenous, Human – Slra 10% Liquid (Asceniv™) HCPCS Code J1599: Billing Guidelines

Tuesday, January 28, 2020

Givosiran Injection, for Subcutaneous Use (Givlaari™) HCPCS Code J3490: Billing Guidelines

Tuesday, January 28, 2020

Luspatercept-aamt for Injection, for Subcutaneous Use (Reblozyl®) HCPCS Code J3590: Billing Guidelines

Tuesday, January 28, 2020

Pegfilgrastim-bmez Injection, for Subcutaneous Use (Ziextenzo™) HCPCS Code J3590: Billing Guidelines

Tuesday, January 28, 2020

Billing Code Update for Nurse Practitioners and Physician Assistants

Tuesday, January 21, 2020

Update: Draft Provider Manual for Tailored Care Management

Friday, January 17, 2020

Clinical Coverage Policies

Monday, January 13, 2020

Federal Enrollment Application Fee Increase for Year 2020

Monday, January 13, 2020